---
figid: PMC11693700__fgene-15-1453191-g006
figtitle: Deubiquitylase in the PI3K/AKT/mTOR signaling pathway signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11693700
filename: fgene-15-1453191-g006.jpg
figlink: /pmc/articles/PMC11693700/figure/F6/
number: F6
caption: The role of Deubiquitylase in the PI3K/AKT/mTOR signaling pathway signaling
  pathway. VHL can ubiquitinate and degrade RAPTOR, an integral component of the mTORC1
  complex, thereby inhibiting the AKT signaling pathway. VHL can also directly inhibit
  AKT activity to inhibit the AKT signaling pathway. In VHL-deficient cells, HIF-2α
  upregulates SLC7A5 amino acid carrier expression to enhance mTORC1 activity. ZNRF1
  can polyubiquitinate and degrade AKT, and also interacts with LZTFL1 to inhibit
  AKT. Fbxw7 ubiquitinates and degrades mTOR. USP46 inhibits AKT levels. OTUD1 deubiquitinates
  and stabilizes PTEN, and regulates its inhibitory effect on AKT through deubiquitination
papertitle: Dysregulation of ubiquitination modification in renal cell carcinoma
reftext: Hongjie You, et al. Front Genet. 2024;15(NA).
year: '2024'
doi: 10.3389/fgene.2024.1453191
journal_title: Frontiers in Genetics
journal_nlm_ta: Front Genet
publisher_name: Frontiers Media SA
keywords: E3 ubiquitin ligases | renal cell carcinoma (RCC) | ubiquitination | PROTAC
  | immunotherapy | deubiquitinase
automl_pathway: 0.9356586
figid_alias: PMC11693700__F6
figtype: Figure
redirect_from: /figures/PMC11693700__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11693700__fgene-15-1453191-g006.html
  '@type': Dataset
  description: The role of Deubiquitylase in the PI3K/AKT/mTOR signaling pathway signaling
    pathway. VHL can ubiquitinate and degrade RAPTOR, an integral component of the
    mTORC1 complex, thereby inhibiting the AKT signaling pathway. VHL can also directly
    inhibit AKT activity to inhibit the AKT signaling pathway. In VHL-deficient cells,
    HIF-2α upregulates SLC7A5 amino acid carrier expression to enhance mTORC1 activity.
    ZNRF1 can polyubiquitinate and degrade AKT, and also interacts with LZTFL1 to
    inhibit AKT. Fbxw7 ubiquitinates and degrades mTOR. USP46 inhibits AKT levels.
    OTUD1 deubiquitinates and stabilizes PTEN, and regulates its inhibitory effect
    on AKT through deubiquitination
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPAS1
  - PTEN
  - OTUD1
  - ZNRF1
  - VHL
  - USP46
  - AKT1
  - AKT2
  - AKT3
  - LZTFL1
  - FBXW7
  - SLC7A5
  - MTOR
  - RPTOR
  - MAPKAP1
  - RICTOR
  - MLST8
  - ptenb
  - otud1
  - znrf1
  - vhl
  - usp46
  - lztfl1
  - fbxw7
  - slc7a5
  - mlst8
  - RAPTOR
---
